When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
The New York Gaming Commission, during a Jan. 21 public hearing, heard the pros and cons of having different medication rules for Thoroughbred and Standardbred racehorses.
- By Tom LaMarra
An official with the RMTC said confidentiality agreements used when the organization considers research to set thresholds and withdrawal times for medications are necessary because of scientific factors.
Regulatory administration of race-day anti-bleeding medication in Kentucky has provided a clearer picture of drug testing and produced added security benefits, officials said.
The Racing Medication and Testing Consortium board of directors has approved thresholds and withdrawal guidelines for six medications that have been identified as having therapeutic purposes.
The Racing Medication and Testing Consortium has hired Dr. Dionne Benson as executive director and chief operating officer.
Most Popular Stories
- Social Inclusion On Derby Path After Big Win
- Effort to Resolve Virginia Dates Fails Again
- Constitution to Make Stakes Debut in FL Derby
- Jockey Club 2014 Fact Book Posted Online
- 'Mandate' Should Be Strong in Rebel Stakes
- Jockey Von Rosen Suffers Serious Injury
- Rosario Rides General a Rod in Florida Derby
- McGaughey Encouraged by Honor Code's Effort
- New York Owner/Breeder Bomze Dies at 76
- Maryland-Based Owner Heft Dies at 94